7.00pm

Opening Reception and Dinner

8.15am

Introduction and Welcome

8.30am

Small Company/Venture Investing Perspective

Even with the global economy slowly making its way toward recovery, finding sustainable sources of capital remains a critical challenge for companies today. Venture capitalists themselves face diminished pools of capital and growing attrition rates – trends that will translate to those companies seeking funding.  In this panel, we look at the current trends in venture financing, explore alternative sources of capital, discuss the most promising areas for investment, and explore whether the worst of the times are over. 

Fred Kornahrens, CEO, KSpine

Antoine Papiernik, Managing Partner, Sofinnova

Tim Haines, Partner, Abingworth

Moderator:  Casey McGlynn

10.15am

Navigating the Markets in Europe

With regulatory pressures mounting and health care system costs being squeezed, more and more US companies are taking a Europe-first approach to clinical testing and commercialization.  But just because the US is difficult doesn’t mean that Europe is easy.  In this session, we’ll hear from CEOs, from both US and European companies, about the opportunities and challenges in tacking the European markets and learn the secrets they’ve gleaned over the years. 

Graeme Brookes, General Manager - CAS/Integrated Technologies, Stanmore Implants

Andy Weiss, CEO/President, CoAxia

Gonzague Issenmann, CEO, Stentys

Conrad Yiu, International Sales Director, EV3

Moderator:  Casey McGlynn

11.30pm

Company of the Year Award

Each year, the Bohemian conference rewards one European company that has risen above all others in executing on its corporate strategy—either through a major trade sale, a successful IPO, or some other significant event.  In this session, we talk with the people behind this year’s Award winner.

2.15pm

How do big Medtech Companies View Europe

The medical device industry today is clearly a global industry, even though most of the largest companies are still US headquartered. For the largest medical device companies, searching for technologies and opportunities world-wide is imperative. In this session, we talk with an European leader of a leading US company to see how their strategies are evolving in a medical device world growing more global every day. 

Rob ten Hoedt, President Europe, Medtronic, Inc

Moderator:  David Cassak

4.00pm

Corporate Spotlight: Turning Troubled Companies Into Winners

Few medical device companies find the path to success either easy or straight forward.  In this panel, we’ll talk to several European executives whose companies have faced difficult times and have had to significantly redirect their course, adopting either a new strategy or a new application for their technology.

Gérard Hascoët, Chairman and CEO, SpineVision

Christof Lenz, CEO, Cardiola AG

Simon Hubbert, CEO, Lombard Medical

Moderator: Steve Levin

8.30am

Where Clinical Medicine and Technology Meet

Innovative device technology doesn’t simply follow medical pathways; it can sometimes steer medicine in new directions.  Think of minimally-invasive surgery and interventional medicine, both important technology-enabled clinical advances.  At the same time, device companies will always try to target unmet clinical needs in their development efforts.  This panel will feature Chief Medical Officers talking about the future of medicine and the role technology play in responding to and driving that direction.

Martin Rothman, VP Medical Affairs, Coronary & Peripheral; Medtronic

Eric Manasse, Chief Medical Officer, Sorin

Moderator: David Cassak

9.45am

Building a Winning Team

Building a successful company requires building a winning team.  Companies need different people with different skill sets as the business develops from conception through research, clinical development and commercialization.  Sometimes those new skills come from within the organization; often it’s important to reach outside to find the talent to build a world class enterprise. Today, the international nature of a medtech company requires executive talent with an understanding of Europe, Asia and the United States. This panel, includes venture investors, executive search professionals and the head of a medtech company, and will explore the issues surrounding building a winning medtech team.

Antoine Papiernik, Managing Partner, Sofinnova

Tim Haines, Partner, Abingworth

Stephan Bochner, Korn Ferry International

Ulrika Hagle, Korn Ferry International

Moderator: Berthold Hackl, CEO, Invendo Medical

11.15am

Exit Strategies

When will the IPO window open again?  How robust will M&A be in the coming year?  When will VCs start investing again?  In this session, we close the Bohemian meeting by returning  to the themes discussed throughout the programme, with perspectives offered by a panel of industry experts on some of the questions most on the minds of medical device executives today.

Sacha Loiseau, CEO, Mauna Kea Technologies

Mark Secrest, Managing Director, Stifel Nicolaus Weisel

Paul Tomasic, Managing Director, Citi

Jed Cohen, Managing Director, Leerink Swann

Moderator: Tracy Lefteroff